AIM
AIM
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
23
$215K
Insider Sales
1
$884
Total Volume
$216K
40 transactions
Net Activity
+$214K
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
High Conviction Accumulation
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •Cluster buying: 5 unique insiders purchased shares, showing strong alignment.
- •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
P - Purchase Insiders
$579.18B total
Equels Thomas K
CEO, Pres
$142K total
Kellner Ted D
Dir
$50K total
Appelrouth Stewart
Dir
$18K total
Mitchell William M
Dir
$6K total
Quick Actions
AIM has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. AIM ranks #555 in insider activity out of 570 tracked companies in its industry.
Over the last 90 days, corporate insiders at AIM (AIM) engaged in a total of 40 transactions reported via SEC Form 4 filings. Among these, 23 were open-market purchases and 1 were sales. The total volume of insider trading reached $216K.
The net insider activity for AIM shows a net buying bias of $214K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 1.64M shares valued at $139.23B on Nov 20, 2024.
REG - AIM - Schedule One - SecondPass Research plc
An Aim stock recovery that’s kicked into gear
AIM ImmunoTech Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting
AIM ImmunoTech Inc. (AIM) Stock Price, News, Quote & History
AIM ImmunoTech’s shareholder meeting adjourned when proxies covered about 32.5% of voting shares.
Aim’s new rules put London back in the running for growth companies
Related News & Analyst Reports
Read original insights and educational research covering AIM and the Unknown sector.
FAQs About AIM Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for AIM.